Cardiovascular Safety of Ranibizumab for Diabetic Macular Edema Still Unclear

Source: Medscape

Monday, April 17, 2017 | Medical Studies


Uncertainty lingers about the cardiovascular safety of intravitreal ranibizumab injections for diabetic macular edema, a pooled analysis of clinical trials shows. The study “includes the largest patient-level data set on the treatment of diabetic macular edema of which we are aware,” said Dr. Marco A. Zarbin of Rutgers University in Newark, New Jersey.

Open in New Window

Comments

You must be logged in to leave a comment.